CVI Holdings Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HERA
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
|
+$19.5M |
| 2 |
Blue Owl Capital
OWL
|
+$19.1M |
| 3 |
LGV
Longview Acquisition Corp. II
LGV
|
+$15.7M |
| 4 |
MBAC
M3-Brigade Acquisition II Corp.
MBAC
|
+$15.6M |
| 5 |
GAPA
G&P Acquisition Corp.
GAPA
|
+$15.5M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 51.2% |
| 2 | Miscellaneous | 12.96% |
| 3 | Technology | 10.5% |
| 4 | Healthcare | 10.03% |
| 5 | Consumer Discretionary | 5.4% |
Similar funds
CVI Holdings's Q2 2021 Portfolio in Review
As of Q2 2021, CVI Holdings held 987 positions worth $1.48B, up 2.2% from $1.45B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
CVI Holdings deployed $45.1M of net new capital in Q2 2021, opening 371 new positions and adding to 2 existing holdings. Its largest new stake was FTAC Hera Acquisition Corp. Class A Ordinary Shares: 2,000,000 shares worth $19.5M.
By sector, the portfolio is most concentrated in Financials at 51% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was Nuvation Bio, an estimated $11M trimmed.
- CVI Holdings's largest Q2 2021 buy was FTAC Hera Acquisition Corp. Class A Ordinary Shares: 2,000,000 shares worth $19.5M.
- CVI Holdings added most to Blue Owl Capital in Q2 2021, an estimated $19.1M increase.
- CVI Holdings's biggest Q2 2021 reduction was Nuvation Bio, cutting an estimated $11M.
- CVI Holdings fully exited Piedmont Lithium Limited American Depositary Receipts in Q2 2021, selling an estimated $38.6M.
- CVI Holdings's ten largest holdings make up 13% of its $1.48B portfolio in Q2 2021.
- CVI Holdings opened 371 new positions and closed 197 in Q2 2021.
- CVI Holdings's portfolio value rose 2.2% quarter-over-quarter to $1.48B.
Based on CVI Holdings's 13F filing for Q2 2021, filed 11 Aug 2021.